| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/08/2004 | US20040131650 Mixture containing viral, bacteria, parasitic antigen |
| 07/08/2004 | US20040131646 Gel delivery vehicles for anticellular proliferative agents |
| 07/08/2004 | US20040131645 Polysaccharide based gel |
| 07/08/2004 | US20040131644 Using phosphatides from poultry embryos |
| 07/08/2004 | US20040131638 Novel composition |
| 07/08/2004 | US20040131626 Administering a genetic engineered polypeptide |
| 07/08/2004 | US20040131606 Product and process for liquefaction of mucus for sputum |
| 07/08/2004 | US20040131602 Methods for enhancing graft survival by modulating heme oxygenase activity |
| 07/08/2004 | US20040131590 Anticancer agents |
| 07/08/2004 | US20040131588 Formulation having mobilising activity |
| 07/08/2004 | US20040131583 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/08/2004 | US20040131555 Mixture of tobramycin in carrier; aerosols; respiratory system disorders |
| 07/08/2004 | US20040131553 Menopause therapy; hormone replacement therapy |
| 07/08/2004 | US20040131552 Prevent drug abuse; blocking release of drug |
| 07/08/2004 | US20040130045 Mixing film-forming, crosslinkable, hydrolyzed polymer and solvent; agitation; adding polymer or organic light emitting diode substance; inducing phase separation of solution; waterproof |
| 07/08/2004 | US20040129174 Molded into components of pharmaceutical dosage forms, e.g. a shell over a core comprising active ingredient |
| 07/08/2004 | US20040129112 Metal-containing materials |
| 07/08/2004 | DE202004006803U1 Kondom mit einer Beschichtung und Zusammensetzung Condom with a coating composition and |
| 07/08/2004 | DE19906978B4 Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit Pharmaceutical composition containing deoxypeganine for the treatment of drug addiction |
| 07/08/2004 | DE10259646A1 Promoting therapy of parodontopathy, especially paradontitis, by topical application of mometasone furoate to teeth or interdental spaces |
| 07/08/2004 | DE10259509A1 Product used for reducing weight, e.g. for producing satiating effect, comprises swellable compound that provides delayed release of nutriments and/or active agents in stomach and intestine |
| 07/08/2004 | DE10259504A1 Production of a spongy material containing an orally ingestible product, useful for delayed and sustained release of drugs, dietary supplements or foods, comprises oxidizing a polymer in aqueous solution |
| 07/08/2004 | DE10259503A1 Production of a composition for oral ingestion, useful for producing pharmaceutical or food products, comprises coating a polymer powder with a hydrophilic liquid |
| 07/08/2004 | DE10111780B4 Brausetablette, Pille oder Dragee, sowie das Verfahren zu ihrer Herstellung Effervescent tablet, pill or coated tablet, and the process for their preparation |
| 07/08/2004 | CA2511451A1 Biomedical devices with antimicrobial coatings |
| 07/08/2004 | CA2511208A1 Controlled release pharmaceutical compositions of tamsulosin |
| 07/08/2004 | CA2510784A1 Methods and compositions for wound management |
| 07/08/2004 | CA2510780A1 Method of treating angiogenic tissue growth |
| 07/08/2004 | CA2510465A1 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| 07/08/2004 | CA2510458A1 Compositions of cholesteryl ester transfer protein inhibitors and hmg-coa reductase inhibitors |
| 07/08/2004 | CA2510199A1 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity |
| 07/08/2004 | CA2510019A1 Process for preparing combination pharmaceutical formulations using supercritical fluids |
| 07/08/2004 | CA2509688A1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
| 07/08/2004 | CA2509382A1 Stimuli-responsive systems for controlled drug delivery |
| 07/08/2004 | CA2508840A1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
| 07/08/2004 | CA2508124A1 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| 07/08/2004 | CA2505599A1 Slow release formulation of clarithromycin |
| 07/07/2004 | EP1435240A2 Solid oral dosage form comprising a combination of methformin and glibenclamide |
| 07/07/2004 | EP1435239A1 Stabilized and easily processable granule of amlodipine maleate |
| 07/07/2004 | EP1435237A1 Prevention of migraine recurrence |
| 07/07/2004 | EP1435233A1 Cyclosporin-based pharmaceutical compositions |
| 07/07/2004 | EP1435232A1 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 07/07/2004 | EP1435231A1 Non-pegylated long-circulating liposomes |
| 07/07/2004 | EP1434990A2 Method for identifying compounds the specifically deplete mast cells |
| 07/07/2004 | EP1434840A1 Low-viscosity opacifiers free from anionic surface-active agents |
| 07/07/2004 | EP1434602A2 Cpg formulations and related methods |
| 07/07/2004 | EP1434601A2 Liposome-encapsulated insulin formulations |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434593A2 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES |
| 07/07/2004 | EP1434590A2 Method for inhibiting the formation of seromas using factor xiii |
| 07/07/2004 | EP1434587A1 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma |
| 07/07/2004 | EP1434574A2 Tolterodine metabolites |
| 07/07/2004 | EP1434572A2 Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles |
| 07/07/2004 | EP1434571A1 Particle immobilized coatings and uses thereof |
| 07/07/2004 | EP1434570A1 Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline |
| 07/07/2004 | EP1434569A1 Therapeutic biological product and method for formation of new vascularised bone |
| 07/07/2004 | EP1434568A1 Extended release pharmaceutical composition containing metformin |
| 07/07/2004 | EP1434567A1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 07/07/2004 | EP1318791B1 Pharmaceutical semi-solid composition of isotretinoin |
| 07/07/2004 | EP1278523B1 Combination of progesterone and mifepristone for cancer therapy |
| 07/07/2004 | EP1212093B1 Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications |
| 07/07/2004 | EP1196195A4 Nasogastric enteral formulations |
| 07/07/2004 | EP1083951A4 Methods of delivering aerosolized polynucleotides to the respiratory tract |
| 07/07/2004 | EP0973484B1 Oil-in-water emulsions for reconstituting lamellarity of the lipid structure of damaged skin |
| 07/07/2004 | EP0825852B1 Liposome drug-loading method and composition |
| 07/07/2004 | EP0825851B1 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
| 07/07/2004 | CN1511053A HSA-free formulations of interferon-Beta |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1511037A Nonintestinal estramustine phosphate and albumin preparations |
| 07/07/2004 | CN1511033A Liquid drug preparations |
| 07/07/2004 | CN1511031A Solid pharmaceutical formulations comprising modafinil |
| 07/07/2004 | CN1511030A Abuse resistant pharmaceutical composition containing capsaicin |
| 07/07/2004 | CN1511027A Percutaneously absorbable patches |
| 07/07/2004 | CN1511026A Granular preparations of gaboxadol |
| 07/07/2004 | CN1509765A Freezed dry preparation of lecithal antibody and its producing method |
| 07/07/2004 | CN1509759A Preparation of enhanced agastache capsules and quality control thereof |
| 07/07/2004 | CN1509728A Agent for eliminating hematoma of tunica vaginolis testis |
| 07/07/2004 | CN1509727A Rose donkey-hide gelatin and its preparation |
| 07/07/2004 | CN1509726A Medicine for treating coronary disease and preparing method thereof |
| 07/07/2004 | CN1509720A Progesterone capsule and preparing method thereof |
| 07/07/2004 | CN1509718A Medicine releasing composition for improving steroid compound stability |
| 07/07/2004 | CN1509717A Skin penetrating paste containing ligustrazine free alkali and its preparation |
| 07/07/2004 | CN1509714A Rifaximin spray |
| 07/07/2004 | CN1509711A Fenfibrate masticatory and its preparation |
| 07/07/2004 | CN1509710A Chinese medicine jell agent and preparing method thereof |
| 07/07/2004 | CN1156581C Liposome encapsulated baccatin III derivative and its usage |
| 07/07/2004 | CN1156461C Improved aqueous solubility pharmaceutical formulations |
| 07/07/2004 | CN1156315C One dose syringe, comprising freeze-dried protein composition, for administering of volume less than 0.5ml |
| 07/07/2004 | CN1156308C Multi-enzyme complex capsule |
| 07/07/2004 | CN1156307C Vagina spry cotaining biological active factor |
| 07/07/2004 | CN1156306C Xinmai dripping pill and preparation process thereof |
| 07/07/2004 | CN1156305C Chinese-medical oinment for treating burn |
| 07/07/2004 | CN1156302C Ointment capable of quick sterilizing AIDS, veneral virus and spermatozoa and preparation process thereof |
| 07/07/2004 | CN1156300C Preparing process and prescription of loquat syrup for treating cough |
| 07/07/2004 | CN1156298C Tumor-eliminating ointment and preparation process |
| 07/07/2004 | CN1156296C Oral liquid containing calcium |
| 07/07/2004 | CN1156294C Stone cleaning liquid for curing stone disease of urinary system |
| 07/07/2004 | CN1156293C Tea Leaf-seed ointment for treating scald and its preparing process |
| 07/07/2004 | CN1156291C Mihaigao made of honey and its preparation |
| 07/07/2004 | CN1156287C Composite medicine for treating myocardosis |